• $1,785.00
    Market Cap
  • 0.00%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
82,563
-20.96%
104,458
+81.34%
57,604
N/A
Cost of Revenue
49,551
-41.62%
84,871
+200.48%
28,245
N/A
Gross Profit
33,012
+68.54%
19,587
-33.28%
29,359
N/A
Sales and Marketing Expense
234,519
+4,380.68%
5,234
+172.89%
1,918
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
88,918
-18.91%
109,657
N/A
N/A
N/A
Total Operating Expenses
1.3M
-10.16%
1.5M
+105.94%
714,162
N/A
Operating Profit
-1.3M
-11.22%
-1.5M
+111.90%
-684,803
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-370,587
+29.88%
-285,327
+4,758.28%
-5,873
N/A
Interest Income and Expense and Net
-370,587
+29.88%
-285,327
+4,758.28%
-5,873
N/A
Total Nonoperating Income and Expense
154
+100.04%
-360,175
+6,625.96%
-5,355
N/A
Income before Taxes
-1.7M
-8.42%
-1.8M
+162.45%
-690,158
N/A
Income Taxes
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.7M
-8.42%
-1.8M
+162.45%
-690,158
N/A
Net Income from Continuing Operations Applicable to Common
-1.7M
-8.42%
-1.8M
+162.45%
-690,158
N/A
Basic EPS and Net Income
0.00
N/A
0.00
N/A
0.00
N/A
Diluted EPS and Net Income
0.00
N/A
0.00
N/A
0.00
N/A
Basic Weighted Average Shares
330.7M
+70.11%
194.4M
+61.53%
120.4M
N/A
Diluted Weighted Average Shares
806.4M
+257.57%
225.5M
+70.16%
132.5M
N/A
Balance Sheet
Cash and Cash Equivalents
44,448
-91.11%
499,766
+843.42%
52,974
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
44,448
-91.11%
499,766
+843.42%
52,974
N/A
Total Current Assets
135,088
-80.08%
678,159
+538.87%
106,150
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
83,420
-13.14%
96,045
N/A
N/A
N/A
Total Assets
218,508
-71.78%
774,204
+513.72%
126,150
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
79,077
+24.38%
63,575
+1,322.26%
4,470
N/A
Total Current Liabilities
868,678
+735.32%
103,994
+5.53%
98,541
N/A
Total Long-Term Debt
253,200
+96.66%
128,750
+6.40%
121,000
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
Total Liabilities
868,678
+735.32%
103,994
+5.53%
98,541
N/A
Retained Earnings
-4.3M
-263.28%
2.6M
+412.17%
-839,669
N/A
Total Stockholders Equity
-650,170
-197.01%
670,210
+2,327.51%
27,609
N/A
Total Shares Outstanding
310.7M
+3.14%
301.2M
+82.65%
164.9M
N/A
Cash Flow
Cash from Operating Activities
-1.0M
+4.05%
-992,428
+60.21%
-619,465
N/A
Capital Expenditures
0
-100.00%
5,702
N/A
N/A
N/A
Cash from Investing Activities
0
+100.00%
-185,702
+828.51%
-20,000
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
577,256
-64.47%
1.6M
+167.93%
606,470
N/A
Financials Ratio
Gross Margin
39.98%
+113.24%
18.75%
-63.21%
50.97%
N/A
Operating Margin
-1,560.42%
+12.33%
-1,389.20%
+16.86%
-1,188.81%
N/A
Return on Assets
-334.19%
-16.94%
-402.35%
-62.94%
-1,085.81%
N/A
Return on Equity
-16,554.55%
+3,088.89%
-519.13%
-518.67%
124.00%
N/A
Revenue Growth
-20.96%
-125.77%
81.34%
N/A
N/A
N/A
Current Ratio
0.16
-97.62%
6.52
+505.38%
1.08
N/A
Cash Ratio
0.05
-98.93%
4.81
+793.92%
0.54
N/A
Debt-to-Equity Ratio
-0.51
-278.08%
0.29
-93.68%
4.54
N/A
Debt-to-Assets Ratio
1.52
+512.20%
0.25
-75.03%
0.99
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow